Page last updated: 2024-08-02 16:58:34

magnosalin

Description

magnosalin: from crude Japanese drug Shin-i; inhibits adjuvant-induced angiogenesis & granuloma formation in the mouse pouch; structure given in first source; RN given refers to cpd without isomeric designation [MeSH]

Magnosalin : no description available [CHeBI]

Cross-References

ID SourceID
PubMed CID10454589
CHEMBL ID156339
CHEBI ID81363
MeSH IDM0190063

Synonyms (11)

Synonym
magnosalin
C17847
1-[2,3-dimethyl-4-(2,4,5-trimethoxyphenyl)-(1r,2r,3r,4r)-cyclobutyl]-2,4,5-trimethoxybenzene
bdbm50110027
chebi:81363 ,
rel-magnosalin
CHEMBL156339 ,
1-[(1r,2r,3r,4r)-2,3-dimethyl-4-(2,4,5-trimethoxyphenyl)cyclobutyl]-2,4,5-trimethoxybenzene
Q27155301
AKOS040762658
81861-74-7

Drug Classes (1)

ClassDescription
lignanAny phenylpropanoid derived from phenylalanine via dimerization of substituted cinnamic alcohols, known as monolignols, to a dibenzylbutane skeleton. Note that while individual members of the class have names ending ...lignane, ...lignene, ...lignadiene, etc., the class names lignan, neolignan, etc., do not end with an "e".

Bioassays (12)

Assay IDTitleYearJournalArticle
AID684426Cytotoxicity against human A549 cells by SRB assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
ISSN: 1464-3405
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.
AID684429Cytotoxicity against human HCT15 cells by SRB assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
ISSN: 1464-3405
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.
AID378128Inhibition of human liver microsome CYP3A4 in assessed as [14C]formaldehyde formation2005Journal of natural products, Jan, Volume: 68, Issue:1
ISSN: 0163-3864
Potent CYP3A4 inhibitory constituents of Piper cubeba.
AID378129Inhibition of human liver microsome CYP2D6 in assessed as [14C]formaldehyde formation2005Journal of natural products, Jan, Volume: 68, Issue:1
ISSN: 0163-3864
Potent CYP3A4 inhibitory constituents of Piper cubeba.
AID684430Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced NO production treated 30 mins before LPS stimulation measured after 24 hrs by Griess reaction2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
ISSN: 1464-3405
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.
AID99817Relative cytotoxicity measured as inhibition of LPS induced TNF alpha production in L929 cells at 10 uM2002Bioorganic & medicinal chemistry letters, Feb-25, Volume: 12, Issue:4
ISSN: 0960-894X
Two neolignans from Perilla frutescens and their inhibition of nitric oxide synthase and tumor necrosis factor-alpha expression in murine macrophage cell line RAW 264.7.
AID684424Antiinflammatory activity in mouse BV2 cells assessed as inhibition of sodium nitroprusside-induced nitrite accumulation at 10 to 20 uM after 180 mins by Griess reaction2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
ISSN: 1464-3405
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.
AID147402Tested for the inhibition of nitric oxide syntheses in murine macrophage cell line RAW 264.72002Bioorganic & medicinal chemistry letters, Feb-25, Volume: 12, Issue:4
ISSN: 0960-894X
Two neolignans from Perilla frutescens and their inhibition of nitric oxide synthase and tumor necrosis factor-alpha expression in murine macrophage cell line RAW 264.7.
AID684425Cytotoxicity against mouse BV2 cells assessed as cell viability at 20 uM by MTT assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
ISSN: 1464-3405
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.
AID684428Cytotoxicity against human SK-MEL-2 cells by SRB assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
ISSN: 1464-3405
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.
AID684432Antiinflammatory activity in mouse BV2 cells assessed as inhibition of LPS-induced iNOS protein expression at 10 to 20 uM treated 30 mins before LPS stimulation measured after 6 hrs by Western blot analysis2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
ISSN: 1464-3405
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.
AID684427Cytotoxicity against human SKOV3 cells by SRB assay2012Bioorganic & medicinal chemistry letters, Oct-01, Volume: 22, Issue:19
ISSN: 1464-3405
Phenolic constituents from the rhizomes of Acorus gramineus and their biological evaluation on antitumor and anti-inflammatory activities.

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's5 (55.56)18.2507
2000's3 (33.33)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
masoprocolcatechols;
lignan;
tetrol
antioxidant;
ferroptosis inhibitor;
geroprotector;
plant metabolite
00low000000
podophyllotoxinfuronaphthodioxole;
lignan;
organic heterotetracyclic compound
antimitotic;
antineoplastic agent;
keratolytic drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
00low000000
arctigeninlignan00low000000
sesaminbenzodioxoles;
furofuran;
lignan
antineoplastic agent;
neuroprotective agent;
plant metabolite
00low000000
picropodophyllinfuronaphthodioxole;
lignan;
organic heterotetracyclic compound
antineoplastic agent;
insulin-like growth factor receptor 1 antagonist;
plant metabolite;
tyrosine kinase inhibitor
00low000000
(+)-Eudesminlignan00low000000
beta-peltatinfuronaphthodioxole;
gamma-lactone;
lignan;
organic heterotetracyclic compound;
phenols
antineoplastic agent;
plant metabolite
00low000000
alpha-peltatinfuronaphthodioxole;
gamma-lactone;
lignan;
organic heterotetracyclic compound;
phenols
antineoplastic agent;
metabolite
00low000000
burseherninaromatic ether;
benzodioxoles;
butan-4-olide;
lignan
plant metabolite00low000000
3,6-Bis(3,4,5-trimethoxyphenyl)-1,3,3a,4,6,6a-hexahydrofuro[3,4-c]furanlignan00low000000
syringaresinolaromatic ether;
furofuran;
lignan;
polyether;
polyphenol
plant metabolite00low000000
diphyllinlignan00low000000
arctiinglycoside;
lignan
00low000000
galgravinaryltetrahydrofuran;
dimethoxybenzene;
lignan;
ring assembly
bone density conservation agent;
neuroprotective agent;
plant metabolite;
platelet aggregation inhibitor
00low000000
plicatic acidlignan00low000000
2,3-bis(3'-hydroxybenzyl)butyrolactonelignan00low000000
cubebinbenzodioxoles;
cyclic acetal;
lactol;
lignan;
secondary alcohol
analgesic;
anti-inflammatory agent;
antimicrobial agent;
histamine antagonist;
plant metabolite;
trypanocidal drug
00low000000
matairesinolgamma-lactone;
lignan;
polyphenol
angiogenesis inhibitor;
anti-asthmatic agent;
phytoestrogen;
plant metabolite
00low000000
2,3-bis(3'-hydroxybenzyl)butane-1,4-diollignan00low000000
planininlignan00low000000
beta-peltatin a methyl etherlactone;
lignan
00low000000
justicidin alignan00low000000
isolariciresinolguaiacols;
lignan;
polyphenol;
primary alcohol
plant metabolite00low000000
4'-demethyldesoxypodophyllotoxinfuronaphthodioxole;
gamma-lactone;
lignan;
methoxybenzenes;
phenols
antineoplastic agent;
antioxidant;
immunosuppressive agent;
plant metabolite
00low000000
pluviatolidearomatic ether;
benzodioxoles;
butan-4-olide;
lignan;
phenols
plant metabolite00low000000
trachelosideglycoside;
lignan
metabolite00low000000
helioxanthinbenzodioxoles;
furonaphthodioxole;
lignan
anti-HBV agent;
antineoplastic agent;
plant metabolite
00low000000
medioresinoldimethoxybenzene;
furofuran;
lignan;
polyphenol
plant metabolite00low000000
kobusinbenzodioxoles;
dimethoxybenzene;
furofuran;
lignan
plant metabolite00low000000
dihydrocubebinbenzodioxoles;
butanediols;
glycol;
lignan
00low000000
gmelinollignan00low000000
mitopodozidelignan00low000000
lariciresinolaromatic ether;
lignan;
oxolanes;
phenols;
primary alcohol
antifungal agent;
plant metabolite
00low000000
anthricinfuronaphthodioxole;
gamma-lactone;
lignan;
methoxybenzenes
antineoplastic agent;
apoptosis inducer;
plant metabolite
00low000000
phyllanthinlignan00low000000
taiwanin cbenzodioxoles;
furonaphthodioxole;
lignan
antineoplastic agent;
plant metabolite;
platelet aggregation inhibitor
00low000000
nortrachelogeninlignan00low000000
yateinbenzodioxoles;
butan-4-olide;
lignan;
methoxybenzenes
plant metabolite00low000000
grandisinlignan00low000000
hinokininbenzodioxoles;
gamma-lactone;
lignan
trypanocidal drug00low000000
yangambinlignan00low000000
trachelogeninlignan00low000000
conidendrinlignanmetabolite00low000000
meso-dihydroguaiaretic acidguaiacols;
lignan
plant metabolite00low000000
terameprocollignan00low000000
LSM-20517lignan00low000000
8-hydroxypinoresinollignan00low000000
savininbenzodioxoles;
gamma-lactone;
lignan
anti-inflammatory agent;
anticoronaviral agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
plant metabolite;
T-cell proliferation inhibitor
00low000000
cycloolivillignan00low000000
4-[4-(4-hydroxy-3-methoxyphenyl)tetrahydro-1H,3H-furo[3,4-c]furan-1-yl]-2-methoxyphenyl hexopyranosideglycoside;
lignan
00low000000
LSM-34734lignan00low000000
hetacillinguaiacols;
lignan;
oxolanes;
polyphenol;
tetrol
plant metabolite00low000000
aiphanolaromatic ether;
benzodioxine;
lignan;
stilbenoid
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor00low000000
macelignanlignan00low000000
manassantin bbenzodioxoles;
dimethoxybenzene;
lignan;
oxolanes;
secondary alcohol
antineoplastic agent;
metabolite
00low000000
(+)-lyoniresinol-3-alpha-O-beta-D-glucopyranosidebeta-D-glucoside;
dimethoxybenzene;
lignan;
monosaccharide derivative;
polyphenol;
primary alcohol;
tetralins
antibacterial agent;
antifungal agent;
metabolite
00low000000
lyoniresinoldimethoxybenzene;
lignan;
polyphenol;
primary alcohol;
tetralins
antineoplastic agent;
metabolite
00low000000
interiotherin baromatic ether;
fatty acid ester;
lignan;
organic heteropentacyclic compound;
oxacycle
anti-HIV agent;
metabolite
00low000000
pravastatinglycoside;
lignan
00low000000
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
pimagedineguanidines;
one-carbon compound
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
EC 1.4.3.4 (monoamine oxidase) inhibitor
2002200222.0low000100
ketoconazoledichlorobenzene;
dioxolane;
ether;
imidazoles;
N-acylpiperazine;
N-arylpiperazine
2005200519.0low000100
cubebinbenzodioxoles;
cyclic acetal;
lactol;
lignan;
secondary alcohol
analgesic;
anti-inflammatory agent;
antimicrobial agent;
histamine antagonist;
plant metabolite;
trypanocidal drug
2005200519.0low000100
omega-n-methylarginineamino acid zwitterion;
arginine derivative;
guanidines;
L-arginine derivative;
non-proteinogenic L-alpha-amino acid
2012201212.0low000010
dihydrocubebinbenzodioxoles;
butanediols;
glycol;
lignan
2005200519.0high000100
quinidinecinchona alkaloidalpha-adrenergic antagonist;
anti-arrhythmia drug;
antimalarial;
drug allergen;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
muscarinic antagonist;
P450 inhibitor;
potassium channel blocker;
sodium channel blocker
2005200519.0low000100
yateinbenzodioxoles;
butan-4-olide;
lignan;
methoxybenzenes
plant metabolite2005200519.0medium000100
hinokininbenzodioxoles;
gamma-lactone;
lignan
trypanocidal drug2005200519.0low000100
alpha-asaroneasaroneanticonvulsant;
GABA modulator
2005200519.0low000100
3-Hydroxy-1-(4-hydroxyphenyl)-1-propanonearomatic ketone2012201212.0high000010
feruloyltyraminetyraminesmetabolite2012201212.0low000010
feruloyltyramine, (z)-isomerhydroxycinnamic acid2012201212.0high000010
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
corticosterone11beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone
human metabolite;
mouse metabolite
1996199628.0low001000
thymidinepyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
1998199826.0low001000
2-naphtholnaphtholantinematodal drug;
genotoxin;
human urinary metabolite;
human xenobiotic metabolite;
mouse metabolite;
radical scavenger
1990199631.8medium004000
lignin1996199628.0low001000
lignans1990200229.8high004100
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Angiogenesis, Pathologic01990199133.5medium002000
Arthritis02002200222.0low000100
Arthritis, Rheumatoid01998199826.0low001000
Dermatoses01990199034.0low001000
Granuloma01990199133.5medium002000
Granulomas01990199133.5medium002000
Peritoneal Diseases01990199034.0low001000
Polyarthritis02002200222.0low000100
Rheumatoid Arthritis01998199826.0low001000
Skin Diseases01990199034.0low001000